1. Home
  2. ADPT vs TREX Comparison

ADPT vs TREX Comparison

Compare ADPT & TREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$27.73

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Trex Company Inc.

TREX

Trex Company Inc.

N/A

Current Price

$50.00

Market Cap

5.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
TREX
Founded
2009
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.3B
IPO Year
2019
1998

Fundamental Metrics

Financial Performance
Metric
ADPT
TREX
Price
$27.73
$50.00
Analyst Decision
Strong Buy
Buy
Analyst Count
8
20
Target Price
$33.86
★ $63.05
AVG Volume (30 Days)
2.1M
★ 2.2M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.89
N/A
EPS
N/A
★ 1.70
Revenue
$276,976,000.00
★ $1,174,267,000.00
Revenue This Year
$10.85
$10.59
Revenue Next Year
$21.60
$5.06
P/E Ratio
★ N/A
$29.76
Revenue Growth
★ 54.77
1.98
52 Week Low
$12.00
$30.60
52 Week High
$32.21
$60.21

Technical Indicators

Market Signals
Indicator
ADPT
TREX
Relative Strength Index (RSI) 49.06 46.61
Support Level $24.02 $41.15
Resistance Level $29.92 $50.04
Average True Range (ATR) 1.71 2.61
MACD -0.09 -0.73
Stochastic Oscillator 31.91 2.85

Price Performance

Historical Comparison
ADPT
TREX

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

Share on Social Networks: